Tangy F - Search Results

1

Antitumor Virotherapy by Attenuated Measles Virus (MV).

Guillerme JB, Gregoire M, Tangy F, Fonteneau JF. Guillerme JB, et al. Among authors: tangy f. Biology (Basel). 2013 Mar 28;2(2):587-602. doi: 10.3390/biology2020587. Biology (Basel). 2013. PMID: 24832799 Free PMC article.

2

Measles virus induces oncolysis of mesothelioma cells and allows dendritic cells to cross-prime tumor-specific CD8 response.

Gauvrit A, Brandler S, Sapede-Peroz C, Boisgerault N, Tangy F, Gregoire M. Gauvrit A, et al. Among authors: tangy f. Cancer Res. 2008 Jun 15;68(12):4882-92. doi: 10.1158/0008-5472.CAN-07-6265. Cancer Res. 2008. PMID: 18559536 Free article.

3

New perspectives in cancer virotherapy: bringing the immune system into play.

Boisgerault N, Tangy F, Gregoire M. Boisgerault N, et al. Among authors: tangy f. Immunotherapy. 2010 Mar;2(2):185-99. doi: 10.2217/imt.10.6. Immunotherapy. 2010. PMID: 20635927 Review.

4

Measles virus vaccine-infected tumor cells induce tumor antigen cross-presentation by human plasmacytoid dendritic cells.

Guillerme JB, Boisgerault N, Roulois D, Ménager J, Combredet C, Tangy F, Fonteneau JF, Gregoire M. Guillerme JB, et al. Among authors: tangy f. Clin Cancer Res. 2013 Mar 1;19(5):1147-58. doi: 10.1158/1078-0432.CCR-12-2733. Epub 2013 Jan 21. Clin Cancer Res. 2013. PMID: 23339127

5

Natural oncolytic activity of live-attenuated measles virus against human lung and colorectal adenocarcinomas.

Boisgerault N, Guillerme JB, Pouliquen D, Mesel-Lemoine M, Achard C, Combredet C, Fonteneau JF, Tangy F, Grégoire M. Boisgerault N, et al. Among authors: tangy f. Biomed Res Int. 2013;2013:387362. doi: 10.1155/2013/387362. Epub 2013 Mar 17. Biomed Res Int. 2013. PMID: 23586034 Free PMC article.

6

Identification of RNA partners of viral proteins in infected cells.

Komarova AV, Combredet C, Sismeiro O, Dillies MA, Jagla B, Sanchez David RY, Vabret N, Coppée JY, Vidalain PO, Tangy F. Komarova AV, et al. Among authors: tangy f. RNA Biol. 2013 Jun;10(6):944-56. doi: 10.4161/rna.24453. Epub 2013 Apr 1. RNA Biol. 2013. PMID: 23595062 Free PMC article.

7

Attenuated measles virus used as an oncolytic virus activates myeloid and plasmacytoid dendritic cells.

Fonteneau JF, Guillerme JB, Tangy F, Grégoire M. Fonteneau JF, et al. Among authors: tangy f. Oncoimmunology. 2013 May 1;2(5):e24212. doi: 10.4161/onci.24212. Oncoimmunology. 2013. PMID: 23762802 Free PMC article.

8

Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response.

Achard C, Boisgerault N, Delaunay T, Roulois D, Nedellec S, Royer PJ, Pain M, Combredet C, Mesel-Lemoine M, Cellerin L, Magnan A, Tangy F, Grégoire M, Fonteneau JF. Achard C, et al. Among authors: tangy f. Oncotarget. 2015 Dec 29;6(42):44892-904. doi: 10.18632/oncotarget.6285. Oncotarget. 2015. PMID: 26539644 Free PMC article.

9

Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination.

Baldo A, Galanis E, Tangy F, Herman P. Baldo A, et al. Among authors: tangy f. Hum Vaccin Immunother. 2016 May 3;12(5):1102-16. doi: 10.1080/21645515.2015.1122146. Epub 2015 Dec 2. Hum Vaccin Immunother. 2016. PMID: 26631840 Free PMC article. Review.

10

Oncolytic virotherapy for human malignant mesothelioma: recent advances.

Boisgerault N, Achard C, Delaunay T, Cellerin L, Tangy F, Grégoire M, Fonteneau JF. Boisgerault N, et al. Among authors: tangy f. Oncolytic Virother. 2015 Sep 10;4:133-40. doi: 10.2147/OV.S66091. eCollection 2015. Oncolytic Virother. 2015. PMID: 27512676 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

188 results

Search Page